Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    LM PAY

    MCap

    EUR24m

    Last close

    EUR37.60

    ▲ 4.00 (11.90%)

    Pathos Communications

    MCap

    GBP18m

    Last close

    GBP0.26

    ▲ 0.00 (0.00%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Edison Talks- Interview with CEO of InMed Pharmaceuticals

Edison Talks- Interview with CEO of InMed Pharmaceuticals

Subscribe
Audio
Follow
Related Content
00:00
00:00

In this episode of Edison Talks, Maxim Jacobs, Edison’s director of research for North America, has an in-depth discussion with Eric A. Adams, the CEO of InMed Pharmaceuticals, the Canada-based biopharmaceutical company focused on maximizing the therapeutic potential of cannabinoids. Max and Eric discuss Cannabinol (CBN), the minor cannabinoid at the heart of InMed’s programs, why the company chose it and the advantages it may have over cannabiodiol (CBD) and tetrahydrocannabinol (THC).

01:32 Overview of InMed Pharmaceuticals 02:21 Introduction to Cannabinol (CBN), the cannabinoid at the heart of InMed’s epidermolysis bullosa (EB) and glaucoma programs 05:55 Is CBN psychoactive? 08:37 Why did InMed choose CBN for EB? 13:11 Can CBN be used for the treatment of glaucoma? 16:27 How does InMed source CBN? 19:13 Please describe the program in EB 26:31 What are the key upcoming milestones for InMed?
Itunes
Overcast
Stitcher

Latest

news

Edison Group reaches global audience of over 8.5 million

news

Milosz Papst in Investors’ Chronicle

news

Neil Shah in AskTraders

news

Jonathan Day in AskTraders

news

Milosz Papst in Investors’ Chronicle

Edison Exhibits- Healthcare demand remains robust

Continue Reading
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.